Drug Overview

Cannabidiol, commonly known as CBD, is a highly studied natural compound extracted from the Cannabis sativa plant. As a medical-grade prescription, it has gained significant attention in modern healthcare. Unlike other compounds from the cannabis plant (like THC), cannabidiol does not cause a “high” or alter a patient’s state of mind.

In the oncology setting, researchers are actively studying cannabidiol for its potential to relieve severe cancer-related symptoms and side effects from chemotherapy. While over-the-counter CBD products are widely available, this guide focuses on the highly purified, prescription-grade form of the medication.

Generic Name: Cannabidiol (CBD)
US Brand Names: Epidiolex®
Drug Class: Cannabinoid / Anticonvulsant
Route of Administration: Oral (taken by mouth as a liquid solution)
FDA Approval Status: FDA-approved for specific neurological conditions. It is currently an investigational drug in oncology (cancer treatment) and is not yet FDA-approved to treat or cure cancer.

What Is It and How Does It Work? (Mechanism of Action)

Cannabidiol works by interacting with the body’s natural communication network, known as the endocannabinoid system (ECS). This system helps control sleep, pain, mood, and immune responses.

At the molecular level, cannabidiol works differently than standard medicines. Instead of directly pressing the “on” or “off” switches (receptors) in the brain like THC does, it works as a regulator on multiple pathways:

GPR55 Receptors: Cannabidiol blocks this specific receptor. In cancer research, blocking GPR55 is being studied because it may stop cancer cells from multiplying.
TRPV1 Receptors: It stimulates these receptors, which are responsible for how the body feels pain and inflammation. This helps dial down severe pain signals.
5-HT1A (Serotonin) Receptors: Cannabidiol activates these receptors, which helps reduce anxiety and severe nausea, two common side effects of chemotherapy.

By working on these pathways simultaneously, cannabidiol helps calm hyperactive nerve signals and reduces severe inflammation throughout the body.

FDA Approved Clinical Indications

While heavily researched in cancer care, prescription-grade cannabidiol is currently only FDA-approved for specific conditions.

Oncological Uses (Cancer-related): * None currently FDA-approved.
- Investigational Uses: Managing cancer-related pain, reducing chemotherapy-induced nausea and vomiting (CINV), easing severe anxiety, and stimulating appetite.
Non-oncological Uses:
- Treatment of seizures associated with Lennox-Gastaut syndrome (in patients 1 year of age and older).
- Treatment of seizures associated with Dravet syndrome (in patients 1 year of age and older).
- Treatment of seizures associated with Tuberous Sclerosis Complex (TSC).

Dosage and Administration Protocols

When prescribed as Epidiolex, the medication is given as a liquid taken by mouth. The dose is carefully calculated based on the patient’s body weight.

Patient Group	Starting Dose	Maintenance Dose	Frequency
Standard Adult/Pediatric	2.5 mg per kg of body weight	5 mg to 10 mg per kg of body weight	Twice daily
Mild Hepatic (Liver) Insufficiency	Standard starting dose	Standard maintenance dose	Twice daily
Moderate Hepatic Insufficiency	1.25 mg per kg	2.5 mg to 5 mg per kg	Twice daily
Severe Hepatic Insufficiency	0.5 mg per kg	1 mg to 2 mg per kg	Twice daily

Note: No specific dose adjustments are currently required for patients with mild to moderate renal (kidney) insufficiency.

Clinical Efficacy and Research Results

Clinical research from 2020 to 2025 has provided important insights into how cannabidiol helps patients, particularly in symptom management.

Symptom Relief in Cancer: In recent supportive care studies, cancer patients using medical-grade cannabidiol reported generalized improvements in pain management and sleep quality. Many patients were able to reduce their reliance on heavy opioid pain medications.
Effects on Disease Progression: Preclinical (laboratory) studies suggest that cannabidiol may promote programmed cell death (apoptosis) in certain tumor cells, such as breast and lung cancer. However, large-scale human trials have not yet proven that cannabidiol increases overall survival rates or stops cancer progression on its own.
Seizure Reduction: In its FDA-approved uses, clinical trials have shown that highly purified cannabidiol can reduce the frequency of severe drop seizures by approximately 30% to 50% compared to a placebo.

Safety Profile and Side Effects

Cannabidiol is generally well-tolerated, but because it is processed by the liver, it can interact with other cancer treatments.

Common Side Effects (>10%)

Somnolence: Extreme sleepiness or fatigue.
Decreased Appetite: Eating less than usual.
Diarrhea: Loose or frequent bowel movements.
Transaminase Elevations: Increases in liver enzymes (seen on blood tests), indicating liver stress.
Malaise: A general feeling of discomfort or weakness.

Serious Adverse Events

Hepatocellular Injury: Severe liver damage, especially when combined with other medications processed by the liver.
Suicidal Behavior and Ideation: Like all anticonvulsant medications, there is a small risk of new or worsening depression and suicidal thoughts.

Management Strategies

Liver Care: Doctors will monitor liver enzymes regularly. If liver enzymes become too high, the doctor will lower the dose or pause the medication until the liver heals.
Managing Sleepiness: Taking the medication at night or adjusting the dose can help manage extreme tiredness.

Connection to Stem Cell and Regenerative Medicine

Cannabidiol is currently an exciting topic in stem cell research, specifically for patients undergoing bone marrow or stem cell transplants for blood cancers. A major risk of these transplants is Graft-Versus-Host Disease (GVHD), where the newly transplanted immune cells attack the patient’s body. Recent clinical research explores using cannabidiol’s powerful anti-inflammatory and immune-regulating properties to prevent GVHD. By calming the immune system without completely shutting it down, cannabidiol may help the new stem cells safely integrate into the patient’s body, promoting healthy tissue regeneration.

Patient Management and Practical Recommendations

Pre-treatment Tests to be Performed

Comprehensive Metabolic Panel (CMP): specifically to check liver function tests (AST, ALT, and total bilirubin) before starting the medication. These tests will be repeated at 1 month, 3 months, and 6 months after starting.
Medication Review: A thorough review of all current medications, as cannabidiol strongly interacts with liver enzymes (CYP450 pathways) that process many chemotherapy drugs.

Precautions During Treatment

Consistency is Key: Taking the medicine with food can significantly increase how much drug your body absorbs. Try to take it the same way (with or without food) every day to keep levels stable.
Safety First: Because it causes sleepiness, do not drive or operate heavy machinery until you know exactly how the medication affects you.

“Do’s and Don’ts” list

DO measure liquid doses accurately using the specialized oral syringe provided by the pharmacy.
DO tell your oncologist about any over-the-counter CBD oils or gummies you are taking, as they can interfere with your cancer treatment.
DON’T stop taking the medication suddenly, as this can cause withdrawal symptoms or trigger seizures.
DON’T drink alcohol while taking this medication, as it can worsen liver stress and extreme sleepiness.

Legal Disclaimer

The information provided in this guide is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Cannabidiol is an active prescription medication with specific FDA-approved indications; its use as a direct treatment for cancer remains investigational. Always consult your oncologist or primary healthcare provider before starting, stopping, or altering any medication or supplement regimen, including over-the-counter CBD products.